Piramal Pharma Limited (NSE: PPLPHARMA)
India
· Delayed Price · Currency is INR 239.70
-2.60 (-1.07%)
Jan 23, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 317.78 billion as of January 23, 2025. Its market cap has increased by 65.89% in one year.
Market Cap
317.78B
Enterprise Value
361.56B
Revenue
87.04B
Ranking
n/a
PE Ratio
701.04
Stock Price
239.70
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 317.78B, an increase of 40.16%. That is a compound annual growth rate of 16.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2025 | 317.78B | -9.97% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,229.31B |
| Divi's Laboratories | 1,544.74B |
| Cipla | 1,153.27B |
| Mankind Pharma | 1,057.64B |
| Apollo Hospitals Enterprise | 994.87B |
| Zydus Lifesciences | 992.05B |
| Aurobindo Pharma | 689.41B |
| Alkem Laboratories | 619.02B |